{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-007031","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2023-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.027347+00:00","generated_at":"2026-06-10T09:38:26.891920+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cosmos Health CCO resigns; shareholders approve reverse split authorization and equity plan","bullets":["Chief Communications Officer Pavlos Ignatiades resigned effective Sept 20, 2023.","Shareholders elected all six director nominees with over 94% affirmative votes each.","Ratified October 2022 public offering (97.77% for) and approved 2023 equity incentive plan (94.19% for).","Board authorized to effect reverse stock split at its discretion; 97.67% of votes in favor."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-007031","json":"https://secwatch.observer/filing/0001477932-23-007031.json","markdown":"https://secwatch.observer/filing/0001477932-23-007031.md","text":"https://secwatch.observer/filing/0001477932-23-007031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T09:38:26.891920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2454da5ecd","claim":"Pavlos Ignatiades resigned as Chief Communications Officer at Cosmos Health Inc..","evidence_excerpt":"On September 20, 2023, Pavlos Ignatiades, our Chief Communications Officer, resigned effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Communications Officer"}],"fact_type":"executive_change"},{"claim_id":"0596c7dcd8a7cb682ddc632cdc18ab6ba5e90562","claim":"Cosmos Health Inc. shareholders approved To ratify the October 2022 Public Offering at the 2023-09-18 meeting.","evidence_excerpt":"2. To ratify the October 2022 Public Offering: For Against Abstain % Votes Affirmative 4,770,999 106,633 2,070 97.77 %","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-09-18"}],"fact_type":"shareholder_vote"},{"claim_id":"a4070068a44c5299b851b04d245d4f13dfa96ca7","claim":"Cosmos Health Inc. shareholders approved To authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company's outstanding common stock at their discretion at the 2023-09-18 meeting.","evidence_excerpt":"4. To authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company’s outstanding common stock at their discretion: For Against Abstain % Votes Affirmative 4,766,157 113,059 486 97.67 %","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-09-18"}],"fact_type":"shareholder_vote"},{"claim_id":"ec3731cc47b63920ff7aa3018097d93c7114ff85","claim":"Cosmos Health Inc. shareholders approved Election of Directors at the 2023-09-18 meeting.","evidence_excerpt":"1. Election of Directors: Nomination For Withheld % Votes Affirmative 01 - Grigorios Siokas 4,606,832 272,870 94.41 % 02 - Demetrios G. Demetriades 4,867,713 11,989 99.75 % 03 - John J. Hoidas 4,872,529 7,173 99.85 % 04 - Dr. Anastasios Aslidis 4,808,836 70,866 98.55 % 05 - Dr. Manfred Ziegler 4,829,695 50,007 98.98 % 06 - Suhel Bhutawala 4,829,523 50,179 98.97 %","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-09-18"}],"fact_type":"shareholder_vote"},{"claim_id":"ed965d6c50c54affbef9d2ca9b49e8db2365494d","claim":"Cosmos Health Inc. shareholders approved To approve the Company's 2023 equity incentive plan at the 2023-09-18 meeting.","evidence_excerpt":"3. To approve the Company’s 2023 equity incentive plan: For Against Abstain % Votes Affirmative 4,596,072 277,077 6,553 94.19 %","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-09-18"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}